cen4uk - cenforce 100 uk - cenforce 200 uk, cenforce uk

DR. CLAUDE MICHEL WISCHIK, PROFESSOR

Professor of Psychiatry | Pharmaceutical Scientist | Biomedical Researcher

General Medical Council (GMC) Reference No: 2760847

Registration and Qualifications

  • Primary medical qualification: BM BS 1980 The Flinders University of South Australia
  • Executive Chairman, TauRx Pharmaceuticals Ltd
  • Birmingham Women’s and Children’s NHS Foundation Trust
  • Pioneer in tau research related to Alzheimer’s and neurodegenerative diseases. Discoverer of the tau protein structure in Alzheimer’s tangles
  • Master’s in Health Sciences – Certificate in Medical Ethics & Compliance, Good Clinical Practice (GCP) Certification
  • Clinical Associate Professor at CEN4UK

ABOUT DOCTOR

Professor Claude Michel Wischik holds the prestigious Chair in Mental Health at the University of Aberdeen in Scotland and serves as the Executive Chairman of TauRx Pharmaceuticals. Originating from France and having spent his formative years in Australia, Professor Wischik embarked on his higher education journey in mathematics and philosophy at the University of Adelaide. He later transitioned to the medical domain, excelling at Flinders University of South Australia where he graduated with First Class Honors. In 1980, with a Commonwealth Scholarship, Professor Wischik ventured to Cambridge, UK, to pursue a PhD under the mentorship of the late Professor Sir Martin Roth and Professor Sir Aaron Klug at the Laboratory of Molecular Biology in Cambridge. It was here that Professor Wischik made groundbreaking discoveries in Alzheimer’s disease research, including the structure of the Paired Helical Filament (PHF) and the identification of Tau protein as a major component.

Under Professor Wischik’s leadership at the Cambridge Bank Laboratory, his team discovered the first pharmaceutically viable Tau Aggregation Inhibitor (TAI), marking a significant advancement in the potential treatment of Alzheimer’s disease (AD). Through their clinico-pathological studies, Professor Wischik and his team underscored the vital relationship between Tau aggregation and the progression of clinical dementia, well ahead of overt tangle pathology, and highlighted the minimal correlation between amyloid pathology and dementia, especially in the initial stages.

SPECIALIST REGISTER

  • Old age psychiatry from 30 Jun 1997
  • General psychiatry from 30 Jun 1997
  • Primary medical qualification BM BS 1980 The Flinders University of South Australia from 14 Apr 1982

Registration and licensing history

Registration and licensing history (since 20 October 2005)
 
From
To
Status
16 Nov 2009PresentRegistered with a licence to practise
20 Oct 200516 Nov 2009Registered

Clinical Focus

  • Congenital Kidney Disease